Incidence and prevalence

11,809views

Incidence and prevalence

Watch later

Watch later

Human herpesvirus 8 (Kaposi sarcoma)
Herpes simplex virus
Human herpesvirus 6 (Roseola)
Adenovirus
Parvovirus B19
Human papillomavirus
BK virus (Hemorrhagic cystitis)
JC virus (Progressive multifocal leukoencephalopathy)
Poliovirus
Coxsackievirus
Rhinovirus
Hepatitis A and Hepatitis E virus
Influenza virus
Mumps virus
Measles virus
Respiratory syncytial virus
Human parainfluenza viruses
Yellow fever virus
Zika virus
Hepatitis C virus
West Nile virus
Norovirus
Rotavirus
HIV (AIDS)
Rabies virus
Rubella virus
Prions (Spongiform encephalopathy)
Candida
Plasmodium species (Malaria)
Trypanosoma cruzi (Chagas disease)
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Mechanisms of antibiotic resistance
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Nuclear structure
DNA structure
Transcription of DNA
Translation of mRNA
Gene regulation
Epigenetics
Amino acids and protein folding
Nucleotide metabolism
DNA replication
Lac operon
DNA damage and repair
Cell cycle
Mitosis and meiosis
DNA mutations
Lesch-Nyhan syndrome
Adenosine deaminase deficiency
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Gel electrophoresis and genetic testing
ELISA (Enzyme-linked immunosorbent assay)
Karyotyping
DNA cloning
Fluorescence in situ hybridization
Mendelian genetics and punnett squares
Hardy-Weinberg equilibrium
Inheritance patterns
Independent assortment of genes and linkage
Evolution and natural selection
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Fragile X syndrome
Huntington disease
Myotonic dystrophy
Friedreich ataxia
Turner syndrome
Klinefelter syndrome
Prader-Willi syndrome
Angelman syndrome
Cri du chat syndrome
Williams syndrome
Alagille syndrome (NORD)
Achondroplasia
Polycystic kidney disease
Familial adenomatous polyposis
Familial hypercholesterolemia
Marfan syndrome
Multiple endocrine neoplasia
Neurofibromatosis
Tuberous sclerosis
von Hippel-Lindau disease
Albinism
Cystic fibrosis
Gaucher disease (NORD)
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Hemochromatosis
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Leukodystrophy
Niemann-Pick disease types A and B (NORD)
Niemann-Pick disease type C
Phenylketonuria (NORD)
Sickle cell disease (NORD)
Tay-Sachs disease (NORD)
Alpha-thalassemia
Beta-thalassemia
Wilson disease
Alport syndrome
X-linked agammaglobulinemia
Fabry disease (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hemophilia
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Muscular dystrophy
Wiskott-Aldrich syndrome
Mitochondrial myopathy
Autosomal trisomies: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Miscellaneous genetic disorders: Pathology review
Human development days 1-4
Human development days 4-7
Human development week 2
Human development week 3
Ectoderm
Mesoderm
Endoderm
Development of the placenta
Development of the fetal membranes
Development of twins
Hedgehog signaling pathway
Development of the digestive system and body cavities
Development of the umbilical cord
Development of the cardiovascular system
Fetal circulation
Development of the face and palate
Pharyngeal arches, pouches, and clefts
Development of the gastrointestinal system
Development of the teeth
Development of the tongue
Development of the axial skeleton
Development of the muscular system
Development of the renal system
Development of the reproductive system
Development of the respiratory system
Cellular structure and function
Cell membrane
Selective permeability of the cell membrane
Extracellular matrix
Cell-cell junctions
Endocytosis and exocytosis
Osmosis
Resting membrane potential
Nernst equation
Cytoskeleton and intracellular motility
Cell signaling pathways
Adrenoleukodystrophy (NORD)
Zellweger spectrum disorders (NORD)
Ehlers-Danlos syndrome
Peroxisomal disorders: Pathology review
Introduction to biostatistics
Types of data
Probability
Mean, median, and mode
Range, variance, and standard deviation
Standard error of the mean (Central limit theorem)
Normal distribution and z-scores
Paired t-test
Two-sample t-test
Hypothesis testing: One-tailed and two-tailed tests
One-way ANOVA
Two-way ANOVA
Repeated measures ANOVA
Correlation
Methods of regression analysis
Linear regression
Logistic regression
Type I and type II errors
Sensitivity and specificity
Positive and negative predictive value
Test precision and accuracy
Incidence and prevalence
Relative and absolute risk
Odds ratio
Mortality rates and case-fatality
DALY and QALY
Direct standardization
Indirect standardization
Study designs
Ecologic study
Cross sectional study
Case-control study
Cohort study
Randomized control trial
Clinical trials
Sample size
Disease causality
Selection bias
Information bias
Confounding
Interaction
Prevention
Major depressive disorder
Suicide
Bipolar and related disorders
Major depressive disorder with seasonal pattern
Generalized anxiety disorder
Social anxiety disorder
Panic disorder
Phobias
Obsessive-compulsive disorder
Body focused repetitive disorders
Post-traumatic stress disorder
Schizophrenia
Delirium
Amnesia
Dissociative disorders
Anorexia nervosa
Bulimia nervosa
Cluster A personality disorders
Cluster B personality disorders
Cluster C personality disorders
Somatic symptom disorder
Factitious disorder
Tobacco use disorder
Opioid use disorder
Cannabis use disorder
Cocaine use disorder
Alcohol use disorder
Bruxism
Insomnia
Narcolepsy (NORD)
Erectile dysfunction
Attention deficit hyperactivity disorder
Disruptive, impulse control, and conduct disorders
Learning disability
Fetal alcohol syndrome
Tourette syndrome
Autism spectrum disorder
Rett syndrome
Mood disorders: Pathology review
Amnesia, dissociative disorders and delirium: Pathology review
Personality disorders: Pathology review
Eating disorders: Pathology review
Psychological sleep disorders: Pathology review
Psychiatric emergencies: Pathology review
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Malingering, factitious disorders and somatoform disorders: Pathology review
Trauma- and stress-related disorders: Pathology review
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Monoamine oxidase inhibitors
Atypical antidepressants
Typical antipsychotics
Atypical antipsychotics
Lithium
Nonbenzodiazepine anticonvulsants
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Psychomotor stimulants

Transcript

Watch video only

Prevalence and incidence are two ways to measure the number of people who have a certain disease in a population.

Prevalence includes all individuals with a disease, or all cases, regardless of when they developed it, divided by the total population.

Whereas incidence includes the new cases of a disease - meaning anyone who develops a disease, over some period of time, divided by the population of individuals that can get that disease.

And both of these have to take into account the population at risk.

Sometimes incidence and prevalence are reported as a proportion of a population like 5 per 1000, or 5 per 100, 000 if it’s a rare disease.

Let’s use a quick analogy to show the relationship between incidence and prevalence.

Imagine a bucket of green marbles - with each marble representing a sick person.

New green marbles keep falling into the bucket - these are the new cases.

We can count up how many green marbles enter the bucket in a year, and that would be the incidence.

Now some marbles also fall out of the bucket - perhaps some cases recover from the disease while other cases die.

Either way, they don’t have the disease anymore and are no longer cases in our bucket.

We can count up the number of green marbles in the bucket and that would be our prevalence.

So the prevalence really depends on the incidence of new cases, the recovery rate of the cases, and the death rate of the cases.

So for prevalence we have all cases of a disease over the population at risk.

If it’s done at some specific moment, like the day that a survey is being done, then it’s called point prevalence.

And occasionally, if it’s done over a period of time, like over a month or year, then it’s called period prevalence.

Now when we have new cases of a disease in a certain period of time, it’s called incidence rate.

This can’t be done at a specific moment, since we need some time window to capture the new cases, and sometimes it’s hard to follow up with everyone for the entire study period.

When this happens, we can use something called person time to find the incidence rate.

That’s when you sum up the time observed for every person during the study period.

Let’s look at an example of incidence rate using person-time.

Let’s say we want to figure out the incidence rate of pneumonia in a small retirement home that has 10 people, and that we do a 3 year study.

Right at the end of year 1, there’s an outbreak and 5 people get pneumonia, and sadly 2 of them died as a result.

At the beginning of year 2, a new person moves into the retirement home.

Key Takeaways

Both incidence and prevalence are ways to measure the number of people who have a certain disease in a population. More specifically, incidence of a disease refers to the number of new cases that occur in a population over a specific period of time; whereas prevalence refers to the number of existing cases that are found in a population at any given point in time.